Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Interventional × talactoferrin alfa × Clear all

Phase

Status

Completed 2 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 505 Cyclophosphamide 355 Radiotherapy 348 Carboplatin 346 Capecitabine 325 Paclitaxel 318 Oxaliplatin 317 Gemcitabine 308 Docetaxel 307 Fluorouracil 279 apatinib 241 Drug Therapy 234 Bevacizumab 223 camrelizumab 212 Etoposide 198 Irinotecan 175 Doxorubicin 174 Dexamethasone 158 Leucovorin 156 Cytarabine 139 sintilimab 138 pembrolizumab 135 anlotinib 135 Pemetrexed 134 toripalimab 123 S 1 (combination) 119 Vincristine 117 Neoadjuvant Therapy 117 Rituximab 116 fludarabine 112

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00706862 2012-03-15

FORTIS-C

Agennix

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡